Stock Quotes in this Article: AVNR, CCM, KBIO

DELAFIELD, Wis. (Stockpickr) -- At Stockpickr, we track daily portfolios of stocks that are the biggest percentage gainers and the biggest percentage losers.

>>5 Stocks Set to Soar on Bullish Earnings

Stocks that are making large moves like these are favorites among short-term traders because they can jump into these names and try to capture some of that massive volatility. Stocks that are making big-percentage moves either up or down are usually in play because their sector is becoming attractive or they have a major fundamental catalyst such as a recent earnings release. Sometimes stocks making big moves have been hit with an analyst upgrade or an analyst downgrade.

Regardless of the reason behind it, when a stock makes a large-percentage move, it is often just the start of a new major trend -- a trend that can lead to huge profits. If you time your trade correctly, combining technical indicators with fundamental trends, discipline and sound money management, you will be well on your way to investment success.

>>Buy These 5 Rocket Stocks to Beat the Market

With that in mind, let's take a closer look at a several stocks under $10 that are making large moves to the upside.

Avanir Pharmaceuticals

Avanir Pharmaceuticals (AVNR), together with its subsidiaries, is engaged in acquiring, developing and commercializing novel therapeutic products for the treatment of central nervous system disorders primarily in the U.S. This stock closed up 3.9% to $5.57 in Tuesday's trading session.

Tuesday's Range: $5.28-$5.65

52-Week Range: $2.62-$6.00

Tuesday's Volume: 3.66 million

Three-Month Average Volume: 2.87 million

From a technical perspective, AVNR jumped sharply higher here right above some near-term support at $5.24 with strong upside volume flows. This stock has been uptrending strong for the last two months, with shares moving higher from its low of $3.07 to its recent high of $5.89. During that uptrend, shares of AVNR have been consistently making higher lows and higher highs, which is bullish technical price action. This spike higher on Tuesday is starting to push shares of AVNR within range of trigger a near-term breakout trade. That trade will hit if AVNR manages to take out Tuesday's intraday high of $5.65 to its 52-week high of $6 with high volume.

Traders should now look for long-biased trades in AVNR as long as it's trending above some near-term support levels at $5.24 or at $5 to $4.89 and then once it sustains a move or close above those breakout levels with volume that hits near or above 2.87 million shares. If that breakout begins soon, then AVNR will set up to enter new 52-week-high territory, which is bullish technical price action. Some possible upside targets off that breakout are $7 to $7.50, or even $8.

Concord Medical Services

Concord Medical Services (CCM), through its subsidiaries, operates radiotherapy and diagnostic imaging centers. This stock closed up 2.2% to $8.12 in Tuesday's trading session.

Tuesday's Range: $7.85-$8.30

52-Week Range: $3.51-$10.08

Tuesday's Volume: 212,000

Three-Month Average Volume: 80,255

From a technical perspective, CCM spiked notably higher here right above some near-term support at $7.50 with above-average volume. This spike higher on Tuesday pushed shares of CCM into breakout territory, since the stock took out some near-term overhead resistance levels at $7.99 to $8.11. Shares of CCM are now starting to trend within range of triggering another key breakout trade. That trade will hit if CCM manages to clear some past resistance levels at $8.48 to $8.64 and then above more resistance at $9 with high volume.

Traders should now look for long-biased trades in CCM as long as it's trending above some key near-term support at $7.50 or above its 50-day at $7.01 and then once it sustains a move or close above those breakout levels with volume that hits near or above 80,255 shares. If that breakout begins soon, then CCM will set up to re-test or possibly take out its next major overhead resistance level at its 52-week high of $10.08.

KaloBios Pharmaceuticals

KaloBios Pharmaceuticals (KBIO), a biopharmaceutical company, primarily develops monoclonal antibody therapeutics for the treatment of respiratory diseases and cancer in the U.S. This stock closed up 7.1% to $2.26 in Tuesday's trading session.

Tuesday's Range: $2.16-$2.34

52-Week Range: $1.66-$6.55

Tuesday's Volume: 500,000

Three-Month Average Volume: 219,805

From a technical perspective, KBIO spiked sharply higher here right above its 50-day moving average of $2.07 with above-average volume. This move pushed shares of KBIO into breakout territory, since the stock took out some near-term overhead resistance at $2.22. Shares of KBIO are now starting to trend within range of triggering another notable breakout trade. That trade will hit if KBIO manages to take out some key overhead resistance levels at $2.35 to $2.66 with high volume.

Traders should now look for long-biased trades in KBIO as long as it's trending above its 50-day at $2.07 or above more near-term support at $2.01 and then once it sustains a move or close above those breakout levels with volume that hits near or above 219,805 shares. If that breakout gets set off soon, then KBIO will set up to re-test or possibly take out its next major overhead resistance levels at $3.28 to $3.69.

To see more stocks that are making notable moves higher, check out the Stocks Under $10 Moving Higher portfolio on Stockpickr.

-- Written by Roberto Pedone in Delafield, Wis.


RELATED LINKS:







Follow Stockpickr on Twitter and become a fan on Facebook.

At the time of publication, author had no positions in stocks mentioned.

Roberto Pedone, based out of Delafield, Wis., is an independent trader who focuses on technical analysis for small- and large-cap stocks, options, futures, commodities and currencies. Roberto studied international business at the Milwaukee School of Engineering, and he spent a year overseas studying business in Lubeck, Germany. His work has appeared on financial outlets including

CNBC.com and Forbes.com.

You can follow Pedone on Twitter at www.twitter.com/zerosum24 or @zerosum24.